COEP (STOCKS)
Coeptis Therapeutics Holdings Inc. Common Stock
$11.560000
-0.620000 (-5.09%)
Prev close: $12.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Mehalick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $74.14M
- Employees
- 7
- P/E (TTM)
- -3.04
- P/B (TTM)
- 5.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $501.00K |
| Cost Of Revenue | $135.47K |
| Gross Profit | $365.53K |
| Nonoperating Income/Loss | -$448.62K |
| Operating Expenses | $13.58M |
| Research and Development | $1.31M |
| Other Operating Expenses | $11.27M |
| Operating Income/Loss | -$13.22M |
| Income/Loss From Continuing Operations After Tax | -$12.39M |
| Income/Loss From Continuing Operations Before Tax | -$13.67M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$12.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $1.28M |
| Net Income/Loss Attributable To Parent | -$13.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.13 |
| Diluted Earnings Per Share | -$8.13 |
| Basic Average Shares | -31,868,020 |
| Diluted Average Shares | -31,868,020 |
| Assets | $14.18M |
| Current Assets | $5.99M |
| Prepaid Expenses | $574.64K |
| Other Current Assets | $5.42M |
| Noncurrent Assets | $8.19M |
| Fixed Assets | $10.02K |
| Intangible Assets | $406.41K |
| Other Non-current Assets | $7.77M |
| Liabilities | $3.26M |
| Current Liabilities | $2.71M |
| Accounts Payable | $783.10K |
| Other Current Liabilities | $1.92M |
| Noncurrent Liabilities | $559.50K |
| Equity | $10.92M |
| Equity Attributable To Noncontrolling Interest | $551.20K |
| Equity Attributable To Parent | $10.37M |
| Liabilities And Equity | $14.18M |
| Net Cash Flow From Operating Activities | -$8.35M |
| Net Cash Flow From Operating Activities, Continuing | -$8.35M |
| Net Cash Flow From Investing Activities | -$3.34M |
| Net Cash Flow From Investing Activities, Continuing | -$3.34M |
| Net Cash Flow From Financing Activities | $12.02M |
| Net Cash Flow From Financing Activities, Continuing | $12.02M |
| Net Cash Flow | $331.68K |
| Net Cash Flow, Continuing | $331.68K |
| Comprehensive Income/Loss | -$12.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.39M |
| Other Comprehensive Income/Loss | $0.00 |